Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Parker
mi
from
Parker, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Singing River Hospital
mi
from
Pascagoula, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Radiation Oncology
mi
from
Peru, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
West Penn Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC-Saint Clair Hospital Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sutter Roseville Medical Center
mi
from
Roseville, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sutter Medical Center Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Missouri Baptist Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Santa Clara Medical Center and Medical Offices
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Palo Alto Medical Foundation-Santa Cruz
mi
from
Santa Cruz, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Minor and James Medical, PLLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Swedish Medical Center - Cherry Hill
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Seneca
mi
from
Seneca, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford USD Medical Center - Sioux Falls
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Cancer Center-Oncology Clinic
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Stamford Hospital, Bennett Cancer Center
mi
from
Stamford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Stockton
mi
from
Stockton, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Tacoma/Valley Radiation Oncology Centers-Saint Joe's
mi
from
Tacoma, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Francis Hospital and Medical Center - Topeka
mi
from
Topeka, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute-Twin Falls
mi
from
Twin Falls, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Saint Mary Regional Cancer Center
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Reading Hospital
mi
from
West Reading, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Wexford Health and Wellness Pavilion
mi
from
Wexford, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Associates in Women's Health
mi
from
Wichita, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Center of Kansas-Wichita Medical Arts Tower
mi
from
Wichita, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KS
Click here to add this to my saved trials
Latent Tuberculosis Infection Clinical Trial
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
Status: Enrolling
Updated: 1/22/2016
Montgomery County Public Health Services, TB, Refugee and Migrant Health
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Melanoma Clinical Trial
Intratumoral Injections of LL37 for Melanoma
Status: Enrolling, Phase I, II
Updated: 6/7/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Imaging Collaterals in Acute Stroke (iCAS)
Status: Enrolling, Phase
Updated: 12/31/1969
Eden Medical Center
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
BioEnergetics and Metabolomics in Cystic Fibrosis
Status: Enrolling, Phase
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Ultrasound to Predict a Pediatric Difficult Airway and Obstructive Sleep Apnea Syndrome in Children
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Trekking Poles to Aid Multiple Sclerosis Gait Impairment
Status: Enrolling
Updated: 7/20/2016
Rowan University School of Osteopathic Medicine
mi
from
Stratford, NJ
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)
Status: Enrolling, Phase III
Updated: 8/26/2014
Texas Diabetes and Endocrinology
mi
from
Round Rock, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Other Clinical Trial
Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction
Status: Enrolling, Phase IV
Updated: 4/8/2018
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center/Floating Hospital for Children
mi
from
Boston, MA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Children's Hospital - Clinical Care Center
mi
from
Houston, TX
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Explorer Clinic, University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
CUMC Research Pharmacy
mi
from
New York, NY
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Vocal Fold Development Clinical Trial
Study to Evaluate the Efficacy of Optical Imaging to Evaluate the Anatomy of the Developing Pediatric Vocal Fold
Status: Enrolling, Phase
Updated: 12/31/1969
Massachusetts Eye and Ear
mi
from
Boston, MA
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lilburn, GA
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Washington DC,
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Center for Advanced Gastroenterology
mi
from
Maitland, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Luke's Health Network
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator's Research Group
mi
from
Brownsburg, IN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Consultants in Gastroenterology
mi
from
Columbia, SC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Center for Gastroenterology, P.C.
mi
from
Decatur, GA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Medisphere Medical Research Center
mi
from
Evansville, IN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwell Health
mi
from
Great Neck, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California, San Diego Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Therapeutic Research Institute of Orange County
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Quality Medical Research Pllc
mi
from
Nashville, TN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Research Of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Associates Research Group
mi
from
San Diego, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Louisiana Research Center, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Gastroenterology Specialists, PC
mi
from
Suwanee, GA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center, Digestive Health
mi
from
Topeka, KS
Click here to add this to my saved trials
Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Spectrum Health
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Columbia University Medical Center Neurological Institute of New York
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Other, Reproductive Clinical Trial
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling, Phase II
Updated: 2/18/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Other, Reproductive Clinical Trial
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling, Phase II
Updated: 2/18/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hematology Clinical Trial
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 8400184
mi
from
Chicago, IL
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Banner MD Anderson Cancer Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
4500 San Pablo Road South
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Local Institution
mi
from
Louisville, KY
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3164530 in Participants With Cancer
Status: Enrolling, Phase I
Updated: 2/1/2016
Pinnacle Oncology Hematology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Hypogonadism Clinical Trial
Oral Testosterone for the Treatment of Hypogonadism in Males
Status: Enrolling, Phase II
Updated: 9/10/2014
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
1 … 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 … 1,845